Peripheral Neuropathy News

Chemotherapy Induced Peripheral Neuropathy - www.oncnursingnews.com/



Chemotherapy Induced Peripheral Neuropathy 
www.oncnursingnews.com/
Chemotherapy-induced peripheral neuropathy is characterized by damage to the nervous system that is a direct result of the medications associated with chemotherapy. Studies state that 30-100% of patients can experience CIPN, depending on the agent, ...

 


Could a pufferfish be the next big thing for neuropathy treatment? - KSAT San Antonio



KSAT San Antonio
 
Could a pufferfish be the next big thing for neuropathy treatment? 
KSAT San Antonio
NEW YORK, N.Y. (Ivanhoe Newswire) - Thirty percent of all Americans will be affected by peripheral neuropathy, a condition that impacts nerves leading to the arms and legs. In many cases, doctors prescribe medicines to help manage the pain, burning and ...

 


Peripheral Neuropathy Can Persist in Cancer Patients Post-Treatment - Specialty Pharmacy Times



Peripheral Neuropathy Can Persist in Cancer Patients Post-Treatment 
Specialty Pharmacy Times
Patients with peripheral neuropathy may experience pain, numbness, and tingling in the hands and feet, despite cessation of chemotherapy.

and more » 


Multivitamins May Reduce Chemotherapy-Induced Peripheral Neuropathy - Cancer Network



Multivitamins May Reduce Chemotherapy-Induced Peripheral Neuropathy 
Cancer Network
Women who take multivitamin supplements before their breast cancer diagnosis and during chemotherapy appear to be less likely to develop the debilitating, often long-lasting symptoms of chemotherapy-induced peripheral neuropathy (CIPN), according to a ...

 


Walking Characteristics of Children with Chemotherapy-Induced Peripheral Neuropathy - Medical News Bulletin



Medical News Bulletin
 
Walking Characteristics of Children with Chemotherapy-Induced Peripheral Neuropathy 
Medical News Bulletin
A recent study, published in Gait & Posture, investigated the gait characteristics of pediatric patients with ALL that exhibit chemotherapy-induced peripheral neuropathy (CIPN). Data were collected from 17 patients (aged 5 years or older) with CIPN and ...

 


Chemo-Induced Peripheral Neuropathy Risk Reduced With Multivitamin - Clinical Pain Advisor



Clinical Pain Advisor
 
Chemo-Induced Peripheral Neuropathy Risk Reduced With Multivitamin 
Clinical Pain Advisor
HealthDay News ? Multivitamin use before diagnosis of breast cancer is associated with reduced risk of symptoms of chemotherapy-induced peripheral neuropathy, according to a study published online in the Journal of the National Cancer Institute.1.

 


Diabetic Neuropathy: Types, Causes, and Risk Factors - Pharmacy Times



Pharmacy Times
 
Diabetic Neuropathy: Types, Causes, and Risk Factors 
Pharmacy Times
Diabetes is a serious condition that is defined by high blood sugar levels. An individual with diabetes is at risk for other conditions and comorbidities, one of the ...

and more » 


FDA Approves New Formula for Pregabalin | MD Magazine - MD Magazine



Market Exclusive
 
FDA Approves New Formula for Pregabalin | MD Magazine 
MD Magazine
Pfizer, pregabalin, lyrica, FDA approval The US Food and Drug Administration (FDA) yesterday announced that it approved a new formula for pregabalin (Lyrica, ...
Lyrica CR Approved By FDA As Patent Expiry Date Nears Market Exclusive

all 3 news articles » 


State grant boosts neuropathy research - Mount Desert Islander



Mount Desert Islander
 
State grant boosts neuropathy research 
Mount Desert Islander
BAR HARBOR ? The Maine Technology Institute (MTI) has awarded a $25,000 seed grant to Sandra Rieger of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and ...

 


Researchers find potential approach to prevent peripheral neuropathy - Gears Of Biz



Researchers find potential approach to prevent peripheral neuropathy 
Gears Of Biz
In discovering how certain chemotherapy drugs cause the nerve damage known as peripheral neuropathy, researchers at Dana-Farber Cancer Institute have ...

and more »